ArticleResearch square2023
Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer's-related biomarkers.
Nicholas J Schork, Jeremy A Elman
Open access · greenFull text readPreprint
In one paragraphArticle in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
2 authors at 2 institutions in 1 country.
Nicholas J SchorkTranslational Genomics Research Institute.
Jeremy A ElmanUniversity of California, San Diego.
Translational Genomics Research Institute · USUniversity of California San Diego · US
Funding
Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0MSystems BiologyU19AG023122 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI FRED H GAGE · 2004 to 2026
$102.6MRegulatory and Human Study Operations (RHSO) Core CU19AG065169 · NIA · UNIVERSITY OF ARIZONA · PI SCHORK, NICHOLAS JOSEPH · 2021 to 2025
$59.8MExceptional Longevity Data Management and Coordinating CenterU24AG078753 · NIA · SAGE BIONETWORKS · PI Christine M. Fabre Suver, Solveig Sieberts · 2022 to 2026
$10.3MIntegrative Omics to enhance therapeutics development for healthy agingUH3AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI MILLER, RICHARD A, SCHORK, NICHOLAS JOSEPH · 2021 to 2024
$3.3MIntegrative Omics to enhance therapeutics development for healthy agingUH2AG064706 · NIA · TRANSLATIONAL GENOMICS RESEARCH INST · PI EVANS, DANIEL SPENCER, MILLER, RICHARD A · 2019 to 2020
$1.4MLinking genetic subtypes of Alzheimer's disease to biological and cognitive heterogeneityK01AG063805 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELMAN, JEREMY A · 2021 to 2024
$516kNIA NIH HHS K01 AG063805NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG023122NIA NIH HHS U19 AG065169NIA NIH HHS U24 AG078753NIA NIH HHS UH2 AG064706NIA NIH HHS UH3 AG064706
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID36909609
PMCPMC10002839
OpenAlexW4322737738
What OpenQuestion holds
Textfull text, public
LicenceCC BY
measurements read4
Read underepoch 390